Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $92.06, but opened at $87.82. Sandoz Group shares last traded at $87.68, with a volume of 510 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Barclays upgraded Sandoz Group from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Three analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Sandoz Group currently has an average rating of “Strong Buy”.
Get Our Latest Research Report on SDZNY
Sandoz Group Trading Up 0.2%
Sandoz Group Company Profile
Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.
The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.
Read More
- Five stocks we like better than Sandoz Group
- Google Cloud Just Gave Rezolve AI a Major Vote of Confidence
- Strategy’s $1.59B Gamble: Checkmate at $80K?
- Semtech Stock Rallies on Strong Q2 Results and Raised Guidance
- Marvell’s Big AI Test Comes One Day After NVIDIA’s Blowout Quarter
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
